|
|
Volumn 30, Issue 8, 1998, Pages 4064-4065
|
|
New trails in transplantation: How to exploit the potential of sirolimus in clinical transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
RAPAMYCIN;
TACROLIMUS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SURVIVAL TIME;
THROMBOCYTOPENIA;
ADRENAL CORTEX HORMONES;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
EUROPE;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
NORTH AMERICA;
SIROLIMUS;
SURVIVAL RATE;
|
|
EID: 0032424338
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01341-4 Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (2)
|
